IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
0.9600
-0.0055 (-0.57%)
At close: Oct 27, 2026, 4:00 PM EDT
0.9700
+0.0100 (1.04%)
After-hours: Oct 27, 2026, 7:30 PM EDT
IN8bio Employees
IN8bio had 18 employees as of June 30, 2026. The number of employees did not change compared to the same quarter last year. That makes IN8bio the 38,613th largest employer in the world and 5,578th in the United States.
Employees
18
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,037,056
Market Cap
9.46M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 18 | 0 | - |
| Mar 31, 2026 | 18 | 0 | - |
| Dec 31, 2025 | 17 | -1 | -5.56% |
| Sep 30, 2025 | 17 | -1 | -5.56% |
| Jun 30, 2025 | 18 | -21 | -53.85% |
| Mar 31, 2025 | 18 | -16 | -47.06% |
| Dec 31, 2024 | 18 | -13 | -41.94% |
| Sep 30, 2024 | 18 | -13 | -41.94% |
| Jun 30, 2024 | 39 | 10 | 34.48% |
| Mar 31, 2024 | 34 | 6 | 21.43% |
| Dec 31, 2023 | 31 | 5 | 19.23% |
| Sep 30, 2023 | 31 | 5 | 19.23% |
| Jun 30, 2023 | 29 | 8 | 38.10% |
| Mar 31, 2023 | 28 | 7 | 33.33% |
| Dec 31, 2022 | 26 | 7 | 36.84% |
| Sep 30, 2022 | 26 | 13 | 100.00% |
| Jun 30, 2022 | 21 | 7 | 50.00% |
| Mar 31, 2022 | 21 | 7 | 50.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioLineRx | 24 |
| Lisata Therapeutics | 21 |
| Theriva Biologics | 16 |
| CalciMedica | 15 |
| Azitra | 13 |
| BioVie | 13 |
| Ensysce Biosciences | 10 |
| Immuron | 8 |
INAB News
- 21 days ago - IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - IN8bio Transcript: Small-Cap Virtual Conference - Transcripts
- 5 weeks ago - IN8bio to Present at Sidoti Small-Cap Virtual Conference - GlobeNewsWire
- 6 weeks ago - IN8bio Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 6 weeks ago - IN8bio Slides: Corporate presentation - Filings
- 6 weeks ago - IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 6 weeks ago - IN8bio Appoints Oxana Polyakova, Ph.D., as Senior Vice President of Research & Development - GlobeNewsWire
- 2 months ago - IN8bio reports Q2 EPS (25c), consensus (37c) - TheFly